News

Mr O’Connor has held positions as vice president of sales, business development manager, and North America sales manager for companies such as Luminex. Mr O’Connor will be based

This milestone officially marks the completion of this randomized, double-blind, placebo-controlled Phase IIb clinical trial which enrolled 351 patients at approximately 40 sites in the US, Germany, Israel

Dr Radaelli is the president and CEO of Dompe International. He currently serves on the board of directors of Dompe Farmaceutici SpA, Dompe SpA, and Philogen SpA, a

This Phase II clinical trial is designed as a double-blind, placebo-controlled Phase II trial which would evaluate safety and efficacy of oral flupirtine versus placebo in fibromyalgia patients.

AnGes plans to conduct due diligence on the pandemic influenza DNA vaccines, and both parties intend to negotiate terms and conditions potentially leading to a license, subject to

The main objective of the multi-center, open-label, safety and efficacy study is to assess patients’ overall response rate to a regimen combining bavituximab with the chemotherapy drugs carboplatin

The technology allows a physician to adjust a patient’s dose of chemotherapy to provide optimal patient exposure to the chemotherapy to help improve efficacy and minimize toxicity during

According to AtheroGenics, the filing became necessary as a result of the company’s substantial debt burden, which created a significant impediment to its ability to effectively develop its

Developed in collaboration with Jean-Marc Fuentes from France, the Wellex is a compressible dynamic extension controller that not only relieves pain but also positively affects the long-term health